France respiratory drug market was valued more than $1.3 billion in 2018 and is anticipated to grow at a substantial rate of 6.0% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors augmenting the growth of the respiratory drug market in the country. […]
